230 related articles for article (PubMed ID: 36336868)
21. High sensitivity LC-MS profiling of antibody-drug conjugates with difluoroacetic acid ion pairing.
Nguyen JM; Smith J; Rzewuski S; Legido-Quigley C; Lauber MA
MAbs; 2019; 11(8):1358-1366. PubMed ID: 31500514
[TBL] [Abstract][Full Text] [Related]
22. A generic workflow for the characterization of therapeutic monoclonal antibodies-application to daratumumab.
Duivelshof BL; Fekete S; Guillarme D; D'Atri V
Anal Bioanal Chem; 2019 Jul; 411(19):4615-4627. PubMed ID: 30617394
[TBL] [Abstract][Full Text] [Related]
23. LC-MS Characterization and Stability Assessment Elucidate Correlation Between Charge Variant Composition and Degradation of Monoclonal Antibody Therapeutics.
Malani H; Shrivastava A; Nupur N; Rathore AS
AAPS J; 2024 Apr; 26(3):42. PubMed ID: 38570351
[TBL] [Abstract][Full Text] [Related]
24. Multiattribute Monitoring of Aggregates and Charge Variants of Monoclonal Antibody through Native 2D-SEC-MS-WCX-MS.
Kumar S; Savane TS; Rathore AS
J Am Soc Mass Spectrom; 2023 Jul; 34(7):1263-1271. PubMed ID: 37327380
[TBL] [Abstract][Full Text] [Related]
25. Drug Loading and Distribution of ADCs After Reduction or IdeS Digestion and Reduction.
Wagner-Rousset E; Colas O; François YN; Heinisch S; Guillarme D; Cianférani S; Beck A
Methods Mol Biol; 2020; 2078():187-195. PubMed ID: 31643057
[TBL] [Abstract][Full Text] [Related]
26. Transition of average drug-to-antibody ratio of trastuzumab deruxtecan in systemic circulation in monkeys using a hybrid affinity capture liquid chromatography-tandem mass spectrometry.
Habara H; Okamoto H; Nagai Y; Oitate M; Takakusa H; Watanabe N
Biopharm Drug Dispos; 2023 Oct; 44(5):380-384. PubMed ID: 37534716
[TBL] [Abstract][Full Text] [Related]
27. An Online Two-Dimensional Approach to Characterizing the Charge-Based Heterogeneity of Recombinant Monoclonal Antibodies Using a 2D-CEX-AEX-MS Workflow.
Kumar S; Peruri V; Rathore AS
J Am Soc Mass Spectrom; 2023 Dec; 34(12):2801-2810. PubMed ID: 37994779
[TBL] [Abstract][Full Text] [Related]
28. Analysis of ADCs by Native Mass Spectrometry.
Hernandez-Alba O; Ehkirch A; Beck A; Cianférani S
Methods Mol Biol; 2020; 2078():197-211. PubMed ID: 31643058
[TBL] [Abstract][Full Text] [Related]
29. Native mass spectrometry and ion mobility characterization of trastuzumab emtansine, a lysine-linked antibody drug conjugate.
Marcoux J; Champion T; Colas O; Wagner-Rousset E; Corvaïa N; Van Dorsselaer A; Beck A; Cianférani S
Protein Sci; 2015 Aug; 24(8):1210-23. PubMed ID: 25694334
[TBL] [Abstract][Full Text] [Related]
30. Custom-Designed Affinity Capture LC-MS F(ab')2 Assay for Biotransformation Assessment of Site-Specific Antibody Drug Conjugates.
Su D; Ng C; Khosraviani M; Yu SF; Cosino E; Kaur S; Xu K
Anal Chem; 2016 Dec; 88(23):11340-11346. PubMed ID: 27779866
[TBL] [Abstract][Full Text] [Related]
31. Hydrophobic interaction chromatography (HIC) method development and characterization of resolved drug-load variants in site-specifically conjugated pyrrolobenzodiazepine dimer-based antibody drug conjugates (PBD-ADCs).
Janaratne T; Wang XC; Becker C; Zhao Y; Leanna R; Pritts W
J Pharm Biomed Anal; 2020 Feb; 179():113027. PubMed ID: 31830625
[TBL] [Abstract][Full Text] [Related]
32. Multi-dimensional LC-MS: the next generation characterization of antibody-based therapeutics by unified online bottom-up, middle-up and intact approaches.
Camperi J; Goyon A; Guillarme D; Zhang K; Stella C
Analyst; 2021 Feb; 146(3):747-769. PubMed ID: 33410843
[TBL] [Abstract][Full Text] [Related]
33. Online Collision-Induced Unfolding of Therapeutic Monoclonal Antibody Glyco-Variants through Direct Hyphenation of Cation Exchange Chromatography with Native Ion Mobility-Mass Spectrometry.
van Schaick G; Domínguez-Vega E; Castel J; Wuhrer M; Hernandez-Alba O; Cianférani S
Anal Chem; 2023 Feb; 95(8):3932-3939. PubMed ID: 36791123
[TBL] [Abstract][Full Text] [Related]
34. Qualitative and quantitative characterization of protein biotherapeutics with liquid chromatography mass spectrometry.
Qu M; An B; Shen S; Zhang M; Shen X; Duan X; Balthasar JP; Qu J
Mass Spectrom Rev; 2017 Nov; 36(6):734-754. PubMed ID: 27097288
[TBL] [Abstract][Full Text] [Related]
35. High-throughput multiplex analysis of mAb aggregates and charge variants by automated two-dimensional size exclusion-cation exchange chromatography coupled to mass spectrometry.
Lambiase G; Inman SE; Muroni M; Lindo V; Dickman MJ; James DC
J Chromatogr A; 2022 May; 1670():462944. PubMed ID: 35344792
[TBL] [Abstract][Full Text] [Related]
36. Current possibilities of liquid chromatography for the characterization of antibody-drug conjugates.
Bobály B; Fleury-Souverain S; Beck A; Veuthey JL; Guillarme D; Fekete S
J Pharm Biomed Anal; 2018 Jan; 147():493-505. PubMed ID: 28688616
[TBL] [Abstract][Full Text] [Related]
37. A Case Study to Identify the Drug Conjugation Site of a Site-Specific Antibody-Drug-Conjugate Using Middle-Down Mass Spectrometry.
Hernandez-Alba O; Houel S; Hessmann S; Erb S; Rabuka D; Huguet R; Josephs J; Beck A; Drake PM; Cianférani S
J Am Soc Mass Spectrom; 2019 Nov; 30(11):2419-2429. PubMed ID: 31429052
[TBL] [Abstract][Full Text] [Related]
38. Middle-Down Multi-Attribute Analysis of Antibody-Drug Conjugates with Electron Transfer Dissociation.
Chen B; Lin Z; Zhu Y; Jin Y; Larson E; Xu Q; Fu C; Zhang Z; Zhang Q; Pritts WA; Ge Y
Anal Chem; 2019 Sep; 91(18):11661-11669. PubMed ID: 31442030
[TBL] [Abstract][Full Text] [Related]
39. An Online Four-Dimensional HIC×SEC-IM×MS Methodology for Proof-of-Concept Characterization of Antibody Drug Conjugates.
Ehkirch A; D'Atri V; Rouviere F; Hernandez-Alba O; Goyon A; Colas O; Sarrut M; Beck A; Guillarme D; Heinisch S; Cianferani S
Anal Chem; 2018 Feb; 90(3):1578-1586. PubMed ID: 29260862
[TBL] [Abstract][Full Text] [Related]
40. Characterization of drug-product-related impurities and variants of a therapeutic monoclonal antibody by higher energy C-trap dissociation mass spectrometry.
Wang D; Wynne C; Gu F; Becker C; Zhao J; Mueller HM; Li H; Shameem M; Liu YH
Anal Chem; 2015 Jan; 87(2):914-21. PubMed ID: 25513708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
